Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next
NEW YORK, Jan 12, 2026, 05:28 EST — Premarket Shares of Hims & Hers Health, Inc. slipped 2.2% in premarket trading Monday, hitting $31.00. The stock had already fallen 6.4% on Friday to $31.69 amid heavy volume. (StockAnalysis) The selloff late in the week came after Amazon Pharmacy began offering Novo Nordisk’s newly approved Wegovy weight-loss pill via insurance plans and a cash-pay option, opening yet another major channel in a market Hims has heavily relied on for growth. (Reuters) This is crucial now since investors see weight loss as Hims’ key growth driver: it attracts fresh users but can